For help on how to get the results you want, see our search tips.
1483 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Summaries of opinion Remove Summaries of opinion filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,
, Revision: 16, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Olumiant (updated)
baricitinib, Arthritis, Rheumatoid
Date of authorisation: 13/02/2017, Revision: 9, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Matever (updated)
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,
, Revision: 25, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Zyllt (updated)
clopidogrel (as hydrogen sulfate), Peripheral Vascular Diseases; Stroke; Acute Coronary Syndrome; Myocardial Infarction
Date of authorisation: 28/09/2009,, Revision: 15, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Retacrit (updated)
epoetin zeta, Anemia; Blood Transfusion, Autologous; Kidney Failure, Chronic; Cancer
Date of authorisation: 18/12/2007,
, Revision: 29, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Isentress (updated)
Raltegravir, HIV Infections
Date of authorisation: 19/12/2007,, Revision: 41, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Pergoveris (updated)
follitropin alfa, lutropin alfa, Infertility, Female
Date of authorisation: 25/06/2007, Revision: 13, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Invokana (updated)
canagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 15/11/2013, Revision: 19, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Tigecycline Accord (updated)
Tigecycline, Soft Tissue Infections; Intraabdominal Infections; Bacterial Infections; Skin Diseases, Infectious
Date of authorisation: 17/04/2020,, Revision: 1, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Lydisilka (updated)
estetrol monohydrate, drospirenone, Contraceptives, Oral
Date of authorisation: 19/05/2021, Revision: 1, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Izba (updated)
travoprost, Ocular Hypertension; Glaucoma, Open-Angle
Date of authorisation: 20/02/2014, Revision: 6, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Drovelis (updated)
drospirenone, estetrol monohydrate, Contraceptives, Oral
Date of authorisation: 19/05/2021, Revision: 1, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Trogarzo (updated)
Ibalizumab, HIV Infections
Date of authorisation: 26/09/2019,
, Revision: 5, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Rivaroxaban Mylan (updated)
rivaroxaban, Venous Thromboembolism; Pulmonary Embolism; Acute Coronary Syndrome; Stroke; Coronary Artery Disease; Peripheral Arterial Disease; Atrial Fibrillation
Date of authorisation: 12/11/2021,, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Truxima (updated)
rituximab, Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis
Date of authorisation: 17/02/2017,, Revision: 14, Authorised, Last updated: 29/11/2021
-
List item
Human medicine European public assessment report (EPAR): Lyrica (updated)
pregabalin, Epilepsy; Anxiety Disorders; Neuralgia
Date of authorisation: 05/07/2004, Revision: 51, Authorised, Last updated: 29/11/2021 -
List item
Human medicine European public assessment report (EPAR): Insulin aspart Sanofi (updated)
insulin aspart, Diabetes Mellitus
Date of authorisation: 25/06/2020,, Revision: 3, Authorised, Last updated: 26/11/2021
-
List item
Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,, 
, Revision: 16, Authorised, Last updated: 26/11/2021
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, , Revision: 15, Authorised, Last updated: 26/11/2021
-
List item
Human medicine European public assessment report (EPAR): Palforzia (updated)
defatted powder of Arachis hypogaea L., semen (peanuts), Peanut Hypersensitivity
Date of authorisation: 17/12/2020,, Revision: 2, Authorised, Last updated: 26/11/2021
-
List item
Human medicine European public assessment report (EPAR): Inbrija (updated)
levodopa, Parkinson Disease
Date of authorisation: 19/09/2019, Revision: 3, Authorised, Last updated: 26/11/2021 -
List item
Human medicine European public assessment report (EPAR): Biktarvy (updated)
bictegravir, emtricitabine, tenofovir alafenamide, fumarate, HIV Infections
Date of authorisation: 21/06/2018,, Revision: 12, Authorised, Last updated: 26/11/2021
-
List item
Human medicine European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis) (updated)
vildagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 30/11/2008, Revision: 23, Authorised, Last updated: 26/11/2021 -
List item
Human medicine European public assessment report (EPAR): Eylea (updated)
aflibercept, Wet Macular Degeneration; Macular Edema; Diabetes Complications
Date of authorisation: 21/11/2012, Revision: 24, Authorised, Last updated: 26/11/2021 -
List item
Human medicine European public assessment report (EPAR): Steglujan (updated)
ertugliflozin l-pyroglutamic acid, sitagliptin phosphate monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 23/03/2018,, Revision: 8, Authorised, Last updated: 26/11/2021